The largest database of trusted experimental protocols

19 protocols using cd19 pacific blue

1

Comprehensive Profiling of PBMC Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binding specificity to human PBMC subsets was assessed by blocking with combined rat and mouse serum followed by incubation with chimeric Ab followed by anti-human IgG4-biotin (Life Technologies) then Streptavidin-PE (SA-PE, Life Technologies). Lymphocyte populations were identified by staining with Ab cocktails comprised of Live/Dead (Zombie) Aqua (Biolegend), anti-human CD3-BV711 or Pacific Blue (clone OTK3), CD19-Pacific Blue (HIB19), CD20-Pacific Blue (2H7), CD56-FITC or Pacific Blue (HCD56), CD14-APC or Pacific Blue (HCD14), CD16-BV785 or Pacific Blue (3G8), HLA-DR-PerCPCy5.5 or PE-Cy7 (L243), CD141-PE-Cy7 (M80), CD1c-Alexa Fluor 700 (L161), CLEC9A-PE (8F9), DEC-205-FITC (all from Biolegend), CD11c-PE-CF594 (B-LY6), CD141-BV711 (1A4) and CD123-BUV395 (7G3) (all from BD), and CADM1-Alexa Fluor 647 (3E1, Jomar/MBL). Samples were acquired on a Becton Dickinson LSR Fortessa X-20 or Beckman Coulter CytoFLEX-S flow cytometer or sorted on a MoFlo Astrios (Beckman Coulter) and analyzed using Flowjo V.9 or 10 software (Treestar).
+ Open protocol
+ Expand
2

Multiparametric Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies for surface staining included CCR7 APC-Cy7 (clone G043H7; Biolegend), CCR7 APC-eFluor780 (clone 3D12; eBioscience), CD4 PE-Cy5.5 (clone S3.5; Invitrogen), CD8 BV711 (clone RPA-T8; Biolegend), CD8 Qdot 605 (clone 3B5; Invitrogen), CD14 BV510 (clone M5E2; Biolegend), CD14 Pacific Blue (clone M5E2; custom), CD14 PE-Cy5 (clone 61D3; Abcam), CD14 PE-Cy7 (clone HCD14; Biolegend), CD16 Pacific Blue (clone 3G8; custom), CD16 PE-Cy5 (clone 3G8; Biolegend), CD16 PE-Cy7 (clone 3G8; Biolegend), CD19 BV510 (clone HIB19; Biolegend), CD19 Pacific Blue (clone HIB19; custom), CD19 PE-Cy5 (clone HIB19; Biolegend), CD19 PE-Cy7 (clone HIB19; Invitrogen), CD45RO ECD (clone UCHL1; Beckman Coulter), CD45RO PE-CF594 (clone UCHL1; BD Biosciences), CD107a PE-Cy5 (clone eBioH4A3; eBioscience), CD107a PE-Cy7 (clone H4A3; Biolegend), and HLA-DR Pacific Blue (clone LN3; Invitrogen). Antibodies for intracellular staining included CD3 BV570 (clone UCHT1; Biolegend), CD3 BV650 (clone OKT3; Biolegend), CD3 Qdot 585 (clone OKT3; custom), CD3 Qdot 650 (clone S4.1; Invitrogen), Eomes Alexa 647 (WD1928; eBioscience), Eomes eFluor 660 (WD1928; eBioscience), IFN-γ Alexa 700 (clone B27; Invitrogen), Perforin BV421 (clone B-D48, Biolegend), Perforin Pacific Blue (clone B-D48; custom), Perforin PE (clone B-D48, Cell Sciences), T-bet FITC (clone 4B10; Biolegend), and T-bet PE (clone 4B10; eBioscience).
+ Open protocol
+ Expand
3

ACE2 Expression Quantification in Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates (100 000 cell equivalents per well) were probed with antibodies to GAPDH (R&D Systems), β-actin (Sigma-Aldrich), and ACE2 (Novus Biologicals). The appropriate secondary horseradish peroxidase antibodies were used for imaging with an iBright 1500 system (Invitrogen), and ImageJ (Version 1.49 23) software was used for quantification. Cell surface expression was measured by means of flow cytometry using ACE2–phycoerythrin (PE) (Novus Biologicals), as recommended by the manufacturer. Primary cell populations were incubated with CD19-PacificBlue (BioLegend), CD3–fluorescein isothiocyanate (FITC), CD4-FITC, CD8-FITC, CD14– allophycocyanin (APC), and CD56-AlexaFluor700 (all BD Biosciences). Primary cells were treated with human immunoglobulin G (10 µg/1 million cells) to block Fc receptors on B cells. Data were acquired on an LSR II flow cytometer using a single-stained AbC bead kit (ThermoFisher) for compensation [17 (link)]. Viable cells were gated based on forward and side scatter, doublets were excluded, and “fluorescence minus 1” controls were assessed. PE quantitation beads (BD Quantibrite) were analyzed, according to the manufacturer’s instructions, to quantify ACE2 molecules per cell. At least 10 000 total events were collected in each experiment and the FlowJo program (Tree Star) was used for data analysis.
+ Open protocol
+ Expand
4

MSC Surface Marker Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze cell-surface expression of typical MSC surface marker proteins, cells were detached, counted and labeled with the following anti-human antibody conjugates: CD44 - APC; CD73 - APC; CD90 - PE; CD14 - PerCp/Cy5.5; CD45 - PerCp/Cy5.5; CD31 - FITC; CD34 - FITC; CD19 - Pacific Blue; HLA-DR - Pacific Blue (all from Biolegend) and also CD105 PE (eBioscience, Inc., San Diego, CA, USA). The mouse isotype antibodies used as the respective controls were: Pacific Blue IgG1; Pacific Blue IgG2a; IgG1k PErCp/Cy5.5; IgG2a PerCp/Cy5.5; IgG1k PE; IgG1k APC and IgG1k FITC (all from Biolegend®, San Diego, CA, USA). A total of 10,000 labeled cells were acquired using a Gallios Flow cytometer (Beckman Coulter) and results analyzed with Kaluza software (Beckman Coulter, Inc., Carlsbad, CA, USA).
+ Open protocol
+ Expand
5

Immunophenotyping of Gene-Targeted hMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunophenotyping was performed to determine cell surface marker profiles of hMSCs before and after gene targeting according to ISCT consensus28 (link). Cells were trypsinized and stained to analyze with flow cytometry, with the following monoclonal antibodies (and clone IDs) from BioLegend Inc. (San Diego, CA): CD105-PE/Cy7 (43A3), CD73-APC (AD2), CD90-PerCP/Cy5.5 (5E10), CD14-Pacific Blue (M5E2), CD19-Pacific Blue (SJ25C1), CD34-Pacific Blue (581), CD45-Pacific Blue (2D1), and HLA-DR-Pacific Blue (L243). All antibodies were used at 1:100 dilutions for staining.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were thawed and stained with antibodies against CD19 Pacific Blue, CD21 FITC, IgD PE, CD24 PEcy7, CD27 APC Cy7 (Biolegend); IgM FITC, IgD FITC, and IgM PE (BD Biosciences); CD38 APC and IgD APC (Miltenyi Biotec), and with 7AAD or FVD 506 (eBioscience) as viability markers. After staining, cells were fixed with a 1% paraformaldehyde/PBS solution before analysis on a MACS-Quant Analyzer (Miltenyi Biotec). Flow cytometry data analysis was performed using Flowjo data analysis software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
7

Comprehensive Cell Surface Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyse cell-surface expression, cells were detached, counted, and labelled with the following anti-human antibodies: CD14-PerCp/Cy5.5; CD19-Pacific Blue; CD31-FITC; CD34-FITC; CD44-APC; CD45-PerCp/Cy5.5; CD73-APC; CD90-PE and HLA-DR-Pacific Blue, CD200-Alexa Fluor 647, CD273-PE and CD274-PE all from Biolegend (San Diego, CA, USA), and also CD105-PE (eBioscience, San Diego, CA, USA). The mouse isotype antibodies used as the respective controls were Pacific Blue IgG1; Pacific Blue IgG2a; IgG1k PErCp/Cy5.5; IgG2a PerCp/Cy5.5; IgG1k PE; IgG1k APC and IgG1k FITC, Alexa Fluor 647 IgG1k, and PE IgG1k all from Biolegend (San Diego, CA, USA). 10 000 labelled cells were acquired using a Gallios Flow cytometer (Beckman Coulter, Brea, CA, USA) and analysed with Kaluza software (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
8

Isolation and Analysis of Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions of spleen and PP cells were prepared by mashing tissues in GentleMACS dissociator (Miltenyi Biotec, Auburn, CA) and filtering through cell strainers. Isolation of lymphocytes from colon and FRT was as previously described [27 (link)] with the following modifications. Mucus and epithelium were removed in PBS supplemented with 1 mM dithiothreitol and 5 mM EDTA. The tissues were then cut into small pieces, suspended in digestion medium, and applied to GentleMACS dissociator. After 30 min incubation at 37°C, additional dissociation was applied and the cell suspensions were transferred to new tubes through cell strainers. Purity and viability of isolated immune cells were validated by flow cytometry and trypan blue staining. B cells were analyzed by staining with anti-mouse CD45 (FITC), CD38 (PECy7), and CD19 (Pacific Blue) (BioLegend, San Diego, CA).
+ Open protocol
+ Expand
9

Multiparameter Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to TPL-2, IκBα, ERK-1, ERK-2, actin were purchased from Santa Cruz Biotechnology, whilst p-p105 (Ser933), p-p38 and p-ERK (Thr185/Tyr187) antibodies were obtained from Invitrogen. Tubulin mAb was kindly provided by Keith Gull (University of Oxford).
A number of fluorescently labelled antibodies for flow cytometry were used against: GMSCF-PE; Gr1-FITC; CD25-PE; TCRβ-PECy5; TCRγδ-PE; Streptavidin-PErCP; Streptavidin-PE were purchased from BD Pharmingen. IL-17A-APC; IFNγ-FITC; CD4-FITC, -PE; F4/80-APC, -PE; Gr1-biotinylated; CD25-APC; CD44-AF450, -FITC; CD45.2-FITC, -AF450; CD45.1-biotinylated; CD11c-PE; CD11b-PE, -biotinylated; MHCII-biotinylated were obtained from eBioscience. CD4-PerCP; CD19-Pacific Blue were purchased from BioLegend. CD4-PE/Texas Red; CD8-PE/Texas Red were obtained from Invitrogen.
+ Open protocol
+ Expand
10

Comprehensive CAR and Immunophenotyping Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS analysis of cell surface CAR and protein expression was performed using an LSR II Fortessa flow cytometer (BD Biosciences). CD22-CAR was detected by incubation with 22-Fc (R&D Systems), followed by incubation with human IgG-specific PE-F(ab)2 (Thermo Fisher Scientific). The following human monoclonal antibodies were used for detection of cell surface proteins: CD22-APC, CD22-PE, CD19-Pacific Blue, CD45-PerCP/Cy5.5, CD3-APC/Cy7, PD1-PE/Cy7, LAG3-APC, TIM3-Pacific Blue, CD8-APC, CD8-PE/Cy7, CD45RA-APC, CD45RO-PE/Cy7, CCR7-Pacific Blue, CD4-Pacific Blue, CD69-APC (all from BioLegend). CD22 site density was determined using QuantiBrite-PE beads (BD Biosciences) using methods previously described (PMID: 20872890). Dead cells were identified using eFluor 506 fixable viability dye (Thermo Fisher Scientific). GFP-expressing leukemia was identified through the FITC channel.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!